Supernus Announces First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Supernus Pharma (SUPN) Tops Q1 EPS by 19c
May 9, 2022 4:42 PM EDTSupernus Pharma (NASDAQ: SUPN) reported Q1 EPS of $0.43, $0.19 better than the analyst estimate of $0.24. Revenue for the quarter came in at $152 million versus the consensus estimate of $150.47 million.
GUIDANCE:
Supernus Pharma sees FY2023 revenue of $640-680 million, versus the consensus of... More
